10.86
3.43%
+0.36
시간 외 거래:
10.6325
-0.2275
-2.09%
Agenus Inc 주식(AGEN)의 최신 뉴스
Agenus announces reverse stock split of common stock - MSN
MSN
Agenus sets FDA meeting for cancer therapy path - Investing.com Canada
Investing.com Canada
Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know - Yahoo Singapore News
Yahoo Singapore News
Agenus sets FDA meeting for cancer therapy path - Investing.com
Investing.com
Agenus sets FDA meeting for cancer therapy path By Investing.com - Investing.com UK
Investing.com UK
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory ... - Business Wire
Business Wire
Therapeutic Vaccines Market Drivers, Size, Biggest Share, - openPR
openPR
Therapeutic Vaccines Market Drivers, Size, Biggest Share, Growth Opportunities 2024-2032 by Pfizer, Transgene ... - openPR
openPR
Agenus Inc. (NASDAQ:AGEN) Short Interest Update - Defense World
Defense World
Agenus Inc. (NASDAQ:AGEN) Short Interest Update - MarketBeat
MarketBeat
Q2 2024 Earnings Forecast for Agenus Inc. (NASDAQ:AGEN) Issued By B. Riley - MarketBeat
MarketBeat
Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know - Yahoo Singapore News
Yahoo Singapore News
Agenus Inc. (NASDAQ:AGEN) to Post Q2 2024 Earnings of ($0.02) Per Share, B. Riley Forecasts - Defense World
Defense World
Q2 2024 EPS Estimates for Agenus Inc. Raised by Analyst (NASDAQ:AGEN) - Defense World
Defense World
Ahead of the Bell: Agenus shares tumble - Yahoo New Zealand News
Yahoo New Zealand News
Q2 2024 EPS Estimates for Agenus Inc. Lifted by William Blair (NASDAQ:AGEN) - Defense World
Defense World
Q2 2024 Earnings Forecast for Agenus Inc. Issued By HC Wainwright (NASDAQ:AGEN) - MarketBeat
MarketBeat
Q2 2024 Earnings Forecast for Agenus Inc. Issued By HC Wainwright (NASDAQ:AGEN) - MarketBeat
MarketBeat
Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down - Yahoo Movies UK
Yahoo Movies UK
Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results - Simply Wall St
Simply Wall St
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks Investment Research
Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and Financial Updates - GuruFocus.com
GuruFocus.com
Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Yahoo Finance
News Flash: Analysts Just Made A Substantial Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts - Yahoo News UK
Yahoo News UK
Agenus: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Agenus Reports First Quarter 2024 Results - citybiz
citybiz
Ligand invests $75 million in Agenus cancer drug development - Investing.com
Investing.com
Agenus (AGEN) Q1 2024 Earnings Call Transcript
The Motley Fool
Agenus' (AGEN) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
MarketBeat
Agenus: Q1 Earnings Snapshot - The Washington Post
The Washington Post
Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments - Yahoo Finance
Yahoo Finance
Agenus Reports First Quarter 2024 Results - br.ADVFN.com
br.ADVFN.com
Agenus Secures Strategic Finance Deal with Ligand - TipRanks.com - TipRanks
TipRanks
Agenus Reports First Quarter 2024 Results - Business Wire
Business Wire
Ligand invests $75 million in Agenus cancer drug development - Investing.com Nigeria
Investing.com Nigeria
Analysts Estimate Agenus (AGEN) to Report a Decline in Earnings: What to Look Out for - Yahoo Singapore News
Yahoo Singapore News
Agenus (AGEN) to Release Earnings on Tuesday - Defense World
Defense World
Agenus (AGEN) to Release Earnings on Tuesday - Defense World
Defense World
Agenus (NASDAQ:AGEN) adds US$89m to market cap in the past 7 days, though investors from five years ago are still down 78% - Simply Wall St
Simply Wall St
Agenus regains NASDAQ compliance with bid price rule - Investing.com Australia
Investing.com Australia
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement - Elk Valley Times
Elk Valley Times
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
Business Wire
Time Is Running Out For Agenus To Raise Cash (NASDAQ:AGEN) - Seeking Alpha
Seeking Alpha
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
The Motley Fool
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting - Business Wire
Business Wire
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting - Business Wire
Business Wire
자본화:
|
볼륨(24시간):